dihexa peptide injection dosage dihexa dosage GHK-CU 100mg Dihexa Peptide: Benefits, Mechanism, and

At this concentration, 1 unit = 0.01 mL 33.3 mcg on a U100 insulin syringe

OASIS trials: establishing effective doses Phase 2 OASIS 1 findings: Tested multiple dose levels: 0.3mg, 0.6mg, 1.2mg, 2.4mg, 4.5mg weekly Duration: 26 weeks Primary endpoint: Weight loss at each dose Dose-response results: 0.3mg weekly: ~4% body weight loss 0.6mg weekly: ~6% body weight loss 1.2mg weekly: ~8% body weight loss 2.4mg weekly: ~10% body weight loss 4.5mg weekly: ~12% body weight loss Key insight: Clear dose-response relationship

Mechanism of Action at Cellular Level Angiogenic Pathway Activation One of the most extensively characterized mechanisms of BPC-157 involves its pro-angiogenic effects mediated through the vascular endothelial growth factor receptor 2 (VEGFR2) signaling system

Pharmacol Rev 76:12911325

It has shown strong anti-proliferative and anti-metastatic effects in vitro and in vivo and also reduced the production of inflammatory cytokines such as IL-6 and TNF- thus suggesting it to be an important therapeutic agent against cancer progression

Strawbridge, R., Young, A